MUC‐1 Epithelial Tumor Mucin‐Based Immunity and Cancer Vaccines

Immunological Reviews

Volumn 145, Issue 1, 1995, Pages 61-89

  Finn, Olivera J ^a   Jerome, Keith R ^b   Henderson, Robert A ^a   Pecher, Gabriele ^c   Domenech, Nieves ^a   Magarian‐Blander, Julie ^a   Barratt‐Boyes, Simon M ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Section of Pathology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS, TUMOR ASSOCIATED, CARBOHYDRATE; CA 15 3 ANTIGEN; CA 15-3 ANTIGEN; MUCIN; TUMOR ANTIGEN; CANCER VACCINE; CELL ANTIGEN; CELL SURFACE PROTEIN; GLYCOSYLTRANSFERASE; T LYMPHOCYTE RECEPTOR;

ACTIVE IMMUNIZATION; AMINO ACID SEQUENCE; ANIMAL; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; REVIEW; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; BREAST TUMOR; CELL KILLING; CELL TRANSFORMATION; CLINICAL TRIAL; COLON TUMOR; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM TUMOR; GENE EXPRESSION; GENE MUTATION; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; METASTASIS; MOLECULAR CLONING; NONHUMAN; ONCOGENE; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN STRUCTURE; TANDEM REPEAT;

AMINO ACID SEQUENCE; ANIMAL; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-15-3 ANTIGEN; HUMAN; IMMUNOTHERAPY, ACTIVE; MOLECULAR SEQUENCE DATA; MUCINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028989973     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1995.tb00077.x     Document Type: Article

References (102)

1. Subcellular site of synthesis of the N‐acetylgalacto‐saminylserine linkages
2. Vaccinia virus MUC‐1 immunization of mice: immune response and protection against growth of murine tumors bearing the MUC‐1 antigen
3. Activation of specific T cell lines by the antigens avidin and myelin basic protein in the absence of antigen‐presenting cells
4. , Murine immune response to cells transfected with human MUCI: immunization with cellular and synthetic antigens
5. B70 antigen is a second ligand for CTLA‐4 and CD28
6. Human tumor‐specific T cell lines generated from tumor draining lymph node infiltrate
7. Specific, MHC‐unrestricted recognition of tumor‐associated mucins by human cytotoxic T cells
8. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex II molecules
9. Topology of cell adhesion molecules
10. Spatial and temporal expression of an epithelial mucin. MUC‐1, during mouse development
11. Modulation of MUC‐l mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation
12. Gycosyltransferase changes upon differentiation of CaCo‐2 human colonic adenocarcinoma cells
13. Recombinant vaccinia mucin vector: in vitro analysis of expression of tumor‐associated epitopes for antibody and human cytotoxic T‐cell recognition
14. Complexity of expression of antigenic determinants recognized by monoclonal antibodies HMFG‐1 and HMFG‐2. in normal and malignant human mammary epithelial cells
15. Development and characterization of breast cancer reactive monoclonal antibodies directed to the protein core of the human milk mucin
16. A short sequence within the amino acid repeat of a cancer associated mucin contains immunodominant epitopes
17. Endocytosis and intracellular routing of an antibody‐ricin A chain conjugate
18. GM‐CSF and TNF‐a cooperate in the generation of dendritic Laugerhans cells
19. Costimulation of anti‐tumor immunity by the B7 counterreceptor for the T‐lymphocyte molecules CD28 and CTLA‐4
20. A Spectrum of monoclonal antibodies reactive with human mammary tumor cells
21. Identification of a peptide recognized by five melanoma‐specific human cytotoxic T cel lines
22. Risk of breast cancer in relation lo the interval since last full term pregnancy Brit
23. The subcellular localization of apomucin and non‐reducing terminal N‐acetylgalactosamine in porcine sub‐maxillary glands
24. Mucin‐type glycoproteins
25. Specific recognition of human tumor antigens by non‐MHC‐restricted CTL
26. Antigen‐specific. MHC‐unrestricted T cells
27. Tumor rejection antigens recognized by T lymphocytes
28. Biophysical characterization of one‐, two‐, and three‐tandem repeals of human mucin (muc‐1) protein core
29. Synthesis of large multi‐determinant immunogens using the poly‐proline b‐turn helix motif
30. E‐cadheren‐mediated cell‐cell adhesion prevents invasiveness of human carcinoma cells
31. A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats
32. Molecular cloning and expression of human tumor‐associated polymorphic epithelial mucin
33. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 Is selectively exposed in a range of primary carcinomas
34. Molecular cloning of human intestinal mucin cDNAs: sequence analysis and evidence for genetic polymorphism
35. Structures of neutral O‐linkcd polylactosaminoglycans on human skim milk mucins
36. Vaccination against tumor cells expressing breast cancer epithelial tumor antigen
37. The polymorphic epithelial mucin MUC‐1 in human endometrium is regulated with maximal expression in the implantation phase
38. Aberrant O‐linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott‐Aldrich syndrome
39. Biosynthesis of MAM‐6, an epithelial sialomucin. Evidence for involvement of a rare proteolytic cleavage step in the endoplasmic reticulum
40. Cell membrane‐associated mucins and their adhesion‐modulating property
41. Cytotoxic T Cell clones isolated from ovarian tumor infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells
42. Blood group antigen synthesis and degradation in normal and cancerous colonic tissues
43. Expression of Tn, Sialosyl Tn, and T antigens in human pancreas
44. T‐cell un responsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state
45. ‐Why are proteins O‐glycosyiated
46. Adenocarcinoma reactive cytotoxic T lymphocytes recognize an epitope present on the protein core of epithelial mucin molecules
47. Cytotoxic T lymphocytes derived IVom patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells
48. Expression of tumor associated epitopes on EBV‐immortalized B cells and Burkitt's lymphomas transfected with epithelial mucin cDNA
49. Tumor‐specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV‐immortalized B cells transfected with polymorphic epithelial mucin complementary DNA
50. Characteristics relating to ovarian cancer risk: collaborative analysis of seven U. S. case‐control studies. Epithelial ovarian cancer in black women
51. Carbohydrate antigen expression in the adenoma‐carcinoma sequence
52. Humoral immunity against a tandem repeal epilope of human mucin MUC‐l in sera from breast, pancreatic, and colon cancer patients
53. Inhibition or mucin glycosylation by aryl‐N‐acetyl‐a‐galactosaminides in human colon cancer cells
54. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign tumors
55. Isolation and properties of a human pancrealic adenocarcinoma‐associated antigen. DU‐PAN‐2
56. Cloning and sequencing of A human pancreatic tumor mucin cDNA
57. Episialin. a carcinoma‐associated mucin, h generated by a polymorphic gene encoding splice variants with alternative amino termini
58. Suppression of cellular aggregation by high levels of episialin
59. The role of the CD28 receptor during T cell responses to antigen
60. The epithelial sialomucin, episialin is sialylated during recycling
61. Primary Stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro
62. HLA‐unrestricted killing of H SV‐1‐infected mononuclear CELLS. Involvement of cither γ/δ+ or α/β+ human cytotoxic T lymphocytes
63. Specific and effective T‐cell recognition of cells transfecled with a truncated human mucin cDNA
64. Polyproline. beta turn helices. Novel secondary structures proposed for the tandem repeats within rhodopsin, synaptopsin, synexin, gliadin. RNA polymerase II. Hordein, and gluten
65. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies
66. Detection of a pancreatic cancer‐associated antigen (DU‐PAN‐2 antigen) in scrum and ascites of patients with adenocarcinoma
67. The roles of CD4 and CDS in T cell activation
68. Further studies on the relationship between allotranspiantability in the presence of the cell surface glycoprotein epiglycanin in the TA3‐MM mouse mammary carcinoma ascites cell
69. MUC‐1 mucin expression as a marker of progression and metastases of human colorectal carcinoma
70. N‐acetylgalactosamine glycosylation of MUC‐1 tandem repeat peptides by pancreatic tumor cell extracts
71. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP‐N‐acetylgalactosamine: polypeptide N‐acctylgalactosaminyl‐transferase. Studies with the MUC‐1 tandem repeat
72. Sludies of MUC‐I mucin expression and polarity in the mouse mammary gland dem‐onstrale developmental regulation of MUC‐I glycosylation and establish the hormonal bases form RNA expression
73. Tissue‐specific expression of a human polymorphic epithelial mucin (MUCI) in transgenic mice
74. O‐glycosylation of leukosialin in K562‐cclls. evidence for initiation and elongation in early Golgi compartments
75. Activation specificity of arsonate‐reactive T cell clones: structural requirements for hapten recognition and comparision with monoclonal antibodies
76. Binding of antigen in the absence of histocompatibility proteins by arsonate‐reactive T‐cell clones
77. Glycosyttransferase activities in chondrocytes from osteoarthritic and normal human articular cartilage
78. Proliferating dendritic cell progenitors in human blood
79. The Complexity of Mucins
80. Human B‐cell immune responses to the polymorphic epithelial mucin
81. Immunohistochemical expression of tumor‐associated glycoprotein and polymorphic mucin in (he human endometrium during the menstrual cycle
82. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony‐stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a
83. Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”
84. TNF in combination with GM‐CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages
85. Epiglycanin as a membrane glycoprotein. Isolation of plasma membrane from the TA3‐HA tumor cell
86. Unique antigen recognition by herpesvirus‐specific TCR‐7(S cell
87. Unrestricted recognition of a nonpeptide antigen by CDS Cytolytic T lymphocytes
88. Direct evidence for the existence of nominal antigen binding sites of T cell surface Ti α‐β heterodimers of MHC‐restricted T cell clones
89. The interaction of nominal antigen with T cell antigen receptors
90. Temporal aspects of O‐glycosylation and cell surface expression of ascites sialoglycoprotein‐l. the major cell surface siatomucin of 13762 mammary ascites tumor cells
91. The dendritic cell system and its role in immunogenicity
92. Mucin‐type glycoproteins
93. The human tumour‐associated epithelial mucins are coded by an expressed hypervariabte gene locus PUM
94. Expression of MUCl on myeloma cells and induction of HLA‐unrestricted CTL against MUC‐1 from multiple myeloma patient
95. Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: production and reaction with cells in culture
96. Report on the First International Workshop on Carcinoma‐Associated Mucins
97. Porcine submaxiltary gland apomucin contains tandemly repealed, identical sequences of 81 residues
98. + T cells by B7‐transfected melanoma cells
99. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case‐control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Cancer group (see comments)
100. , Human epithelial tumor antigen cDNA sequences
101. Monoclonal antibodies reactive with mucin expressed in breast cancer